Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MCOLN2 | Q8IZK6 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23488079 | 0.65 | — | — | |
| SCHEMBL4407825 | 0.64 | — | — | |
| SCHEMBL3264142 | 0.64 | — | — | |
| SCHEMBL11768987 | 0.64 | — | — | |
| SCHEMBL25008004 | 0.61 | MCOLN2 (0.40) | ALDH1A1CYP2C19CYP1A2POLBTDP1 | |
| SCHEMBL19860035 | 0.61 | MCOLN2 (0.40) | ALDH1A1CYP2C19CYP1A2POLBTDP1 | |
| SCHEMBL23137882 | 0.60 | TSHR (0.38) | ALDH1A1CYP2C19CYP1A2POLBTDP1 | |
| SCHEMBL4413524 | 0.60 | ALDH1A1 (0.50) | ALDH1A1CYP2C19CYP1A2POLBTDP1 | |
| SCHEMBL4409109 | 0.58 | ALDH1A1 (0.49) | ALDH1A1CYP2C19CYP1A2POLBTDP1 | |
| SCHEMBL25009055 | 0.58 | CYP1A2 (0.37) | ALDH1A1CYP2C19CYP1A2POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210171475-A1 | COMPOUNDS | UCL BUSINESS LTD (GB) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171475-A1 | COMPOUNDS | GOT2, GOT1, OAT | ALDH1A1 658/4885CYP2C19 4252/4885CYP1A2 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.